Fuyuan Xing

Immune normalization strategy against suboptimal health status: safe and efficacious therapy using mixed-natural killer cells

M. Shi, Hongjin Wu, Ying Li, 2021, Aging.

Immune Normalization Strategy Against Suboptimal Health Status: Safe and Effective Mixed-Natural Killer Cell Therapy

Y. Li, M. Shi, Hongjin Wu, 2020 .

Treatment, pathological characteristics, and prognosis of pulmonary inflammatory myofibroblastic tumor–a retrospective study of 8 cases

Yu-Chen Huang, Fuyuan Xing, Xiao-jun Li, 2022, Frontiers in Oncology.